Biotest Aktiengesellschaft (ETR:BIO)
42.80
+2.00 (4.90%)
Apr 1, 2025, 5:36 PM CET
ETR:BIO Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Cash & Equivalents | 107.8 | 108.1 | 116.6 | 104.4 | 71.3 | Upgrade
|
Short-Term Investments | - | 10.4 | 12.4 | 8.7 | 12.3 | Upgrade
|
Cash & Short-Term Investments | 107.8 | 118.5 | 129 | 113.1 | 83.6 | Upgrade
|
Cash Growth | -9.03% | -8.14% | 14.06% | 35.29% | 14.05% | Upgrade
|
Accounts Receivable | 193.9 | 196.8 | 159.7 | 146.4 | 162.1 | Upgrade
|
Other Receivables | 1.8 | 10 | 20.2 | 8.6 | 17.1 | Upgrade
|
Receivables | 195.7 | 206.8 | 179.9 | 155 | 179.2 | Upgrade
|
Inventory | 479.5 | 419.1 | 293.8 | 244.6 | 290.1 | Upgrade
|
Prepaid Expenses | - | - | - | 5.8 | - | Upgrade
|
Other Current Assets | 26.5 | 12.1 | 16.7 | 3.7 | 3.4 | Upgrade
|
Total Current Assets | 809.5 | 756.5 | 619.4 | 522.2 | 556.3 | Upgrade
|
Property, Plant & Equipment | 570.8 | 475.7 | 460.3 | 476.7 | 311.3 | Upgrade
|
Long-Term Investments | 2.1 | 11.3 | 5.1 | 4.6 | 2.6 | Upgrade
|
Goodwill | - | 6 | 7.2 | 7.1 | 7.1 | Upgrade
|
Other Intangible Assets | 16.5 | 2.1 | 2.4 | 3.3 | 4.3 | Upgrade
|
Long-Term Deferred Tax Assets | 19.5 | 32.9 | 0.7 | 10.2 | 9.5 | Upgrade
|
Long-Term Deferred Charges | - | 1 | 0.5 | - | - | Upgrade
|
Other Long-Term Assets | 15.6 | 108.8 | 94.3 | 74.6 | 240.2 | Upgrade
|
Total Assets | 1,434 | 1,411 | 1,203 | 1,104 | 1,131 | Upgrade
|
Accounts Payable | 88.4 | 78.1 | 51.1 | 38.8 | 42 | Upgrade
|
Accrued Expenses | - | 7.6 | 6.8 | 9.5 | 5.9 | Upgrade
|
Short-Term Debt | 35.9 | - | - | - | - | Upgrade
|
Current Portion of Long-Term Debt | - | 254.7 | 26.7 | 30 | 21.3 | Upgrade
|
Current Portion of Leases | - | 5.4 | 4.6 | 4.8 | 4.4 | Upgrade
|
Current Income Taxes Payable | 1.1 | 0.9 | 0.3 | 0.5 | 1.2 | Upgrade
|
Current Unearned Revenue | 2.5 | 2.9 | 2.9 | 2.1 | 1.8 | Upgrade
|
Other Current Liabilities | 32.2 | 35.7 | 37.8 | 20.7 | 29 | Upgrade
|
Total Current Liabilities | 160.1 | 385.3 | 130.2 | 106.4 | 105.6 | Upgrade
|
Long-Term Debt | 635.9 | 377.3 | 588.4 | 474.4 | 439.5 | Upgrade
|
Long-Term Leases | - | 52.4 | 24.4 | 22 | 23 | Upgrade
|
Long-Term Deferred Tax Liabilities | 1.1 | 1.1 | 1.2 | 2.2 | 1.2 | Upgrade
|
Other Long-Term Liabilities | 14.5 | 4.8 | 1.9 | 2.3 | 2.9 | Upgrade
|
Total Liabilities | 903.3 | 912 | 831.9 | 723.8 | 689.7 | Upgrade
|
Common Stock | 39.6 | 39.6 | 39.6 | 39.6 | 39.6 | Upgrade
|
Additional Paid-In Capital | 219.8 | 219.8 | 219.8 | 219.8 | 219.8 | Upgrade
|
Retained Earnings | 274.5 | 238.4 | 113.7 | 123 | 185.1 | Upgrade
|
Comprehensive Income & Other | -3.2 | 1.1 | -2 | -2 | -2.9 | Upgrade
|
Total Common Equity | 530.7 | 498.9 | 371.1 | 380.4 | 441.6 | Upgrade
|
Shareholders' Equity | 530.7 | 498.9 | 371.1 | 380.4 | 441.6 | Upgrade
|
Total Liabilities & Equity | 1,434 | 1,411 | 1,203 | 1,104 | 1,131 | Upgrade
|
Total Debt | 671.8 | 689.8 | 644.1 | 531.2 | 488.2 | Upgrade
|
Net Cash (Debt) | -564 | -571.3 | -515.1 | -418.1 | -404.6 | Upgrade
|
Net Cash Per Share | -14.10 | -14.44 | -13.02 | -10.57 | -10.22 | Upgrade
|
Filing Date Shares Outstanding | 40.4 | 39.57 | 39.57 | 39.57 | 39.57 | Upgrade
|
Total Common Shares Outstanding | 40.4 | 39.57 | 39.57 | 39.57 | 39.57 | Upgrade
|
Working Capital | 649.4 | 371.2 | 489.2 | 415.8 | 450.7 | Upgrade
|
Book Value Per Share | 13.14 | 12.61 | 9.38 | 9.61 | 11.16 | Upgrade
|
Tangible Book Value | 514.2 | 490.8 | 361.5 | 370 | 430.2 | Upgrade
|
Tangible Book Value Per Share | 12.73 | 12.40 | 9.14 | 9.35 | 10.87 | Upgrade
|
Land | - | 322.6 | 318 | 315.9 | 311.5 | Upgrade
|
Machinery | - | 339.1 | 335.6 | 443.9 | 157.2 | Upgrade
|
Order Backlog | - | 110.2 | 98.8 | 53.9 | 89.2 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.